Prehabilitation to Patients With Prostate Cancer

Condition(s) studied

Investigational drug(s) / intervention(s)

Prehabilitation: Please refer to arm description

Study summary

The goal of this feasibility study is to test a newly developed, multicomponent prehabilitation intervention to patients with prostate cancer, to improve their resilience to treatment side-effects. The main questions it aims to answer are:

* Are patients and their close relatives willing to take part in prehabilitation?
* What is the acceptability and feasibility of the prehabilitation intervention, seen from the perspectives of patients, their close relatives, and healthcare professionals?
* Are the planned data collection methods feasible, and are there indications of a clinical effect?

Participants will:

* Take part in 12 weeks of physical exercise training
* Attend a 4-day residential prehabilitation intervention, where they receive education and do exercises. After 12 weeks, it is possible to take part in a voluntary follow-up session.
* Patients will respond to questionnaires about their health, symptoms, and quality of life. Patients and their close relatives will attend a group interview. Patients will also complete an exercise diary and brief physical tests

Eligibility

Primary outcome measure(s)

• Change from baseline to follow-up in quality of life measured by EORTC-QLQ-C30 — From baseline (shortly after enrollment) to 24 and 48 weeks later.
  This is a pilot study with one arm only, thus the aim is mainly to test the feasibility of the chosen primary outcome measure, including whether there are tendencies in data that support the aim of participants maintaining stable quality of life. Hence, measured by the European Organization for the Research and Treatment of Cancer Qality of life Questionnaire (EORTC QLQ-C30), the target is unchanged (stable) quality of life measured from baseline to follow-up at 24 and 48 weeks.

Trial sites (3)

More Odense University Hospital trials in Denmark